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Abstract 
Background: Oral mucositis (OM) is a common inflammatory complication among cancerous patients as an ad-
verse effect of chemotherapy and radiotherapy. The aim of this study was to evaluate the effects and identify the 
appropriate route of administration of extract of Zizyphus jujuba in 5-flurouracile induced OM induction in golden 
hamster.
Materials and Methods: In a prospective randomized double blind animal study, OM was induced in 56 male gol-
den hamsters by 5-FU (60 mg/kg) on days 0, 5, and 10 of the study. The cheek pouch was scratched with a sterile 
needle on once daily on days 3 and 4. On days 14-17, 300 mg/kg dietary and 20% Z. jujuba gel and gel base groups 
were treated and then compared with a control group. Microscopic scores and pouch content of malondialdehyde 
(MDA), plus activities of superoxide dismutase and myeloperoxidase in pouch tissue were evaluated.
Results: Histopathology scores of mucositis were lower in the systemic and 20% Z. jujuba gel groups than the gel 
base and control groups (P<0.05). Also, lower MDA level and higher activities of MPO and SOD were detected in 
the systemic and 20% Z. jujuba gel groups in comparison to the gel base and control groups (P<0.001).
Conclusions: The use of Z. jujuba hydroalcoholic extract in systemic and topical forms may be associated with 
reduced intensity of OM, diminished concentration of MDA, and increased activity of MPO and SOD on induced 
OM in golden hamster undergoing 5-FU consumption.
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Introduction
Inflammation is a physiological response of body espe-
cially vascular tissues to harmful stimuli, including in-
fections and tissue injury. As the primary interface bet-
ween the body and the external environment, the skin 
provides the first line of defense against traumatic injury 
and invasion by microbial pathogens (1). On the other 
hand, for orally digested chemical agents and microbio-
ta, oral mucosa is the first line of defense and approxi-
mately in all cases, it suffer histopathological and inflam-
matory injuries. Oral mucositis (OM) was first described 
in 1980s and is the painful inflammation and ulceration 
of the mucous membranes lining the oral cavity, usually 
as an adverse effect of treatment for cancer (2). Both 
chemotherapy and radiation therapy can interfere with 
maturity, cellular growth, and renewal rate of basal epi-
thelial cells, causing changes to normal turnover and 
cell death (3). Indeed, OM is the result of a series of 
inflammatory changes in the epithelial and subepithelial 
cells of the oral mucosa and is a debilitating toxicity of 
chemoradiotherapy for head and neck cancer (HNC) (4, 
5). HNC, principally squamous cell carcinoma, is one of 
the main oncological problems owing to its high morta-
lity rate and the side-effects of the treatment (5). One of 
the chemotherapeutic drugs that can be induced OM is 
fluorouracil (5-FU). 5-FU, which trademarked as Adru-
cil®, Carac® and Efudex®, is a pyrimidine analog drug 
which is used in the treatment of cancer (6). 5-FU has 
been administered systemically for anal, breast, colo-
rectal, esophageal, stomach, pancreatic and skin cancers 
(especially HNC) and topically for actinic keratoses and 
Bowen’s disease (3).
Management of OM via topical approaches should 
address efficacy, patient acceptance, and appropriate do-
sing. Although, we conducted some reports about using 
dexamethasone as chemical drugs for prevention of OM 
(7, 8), but medicinal plants have attracted more attention. 
A large number of plant species contain various bioac-
tive compounds exhibiting health beneficial properties, 
anti-oxidative, anti-inflammatory and mainly antimi-
crobial effects, and their preventive and therapeutic use 
increases (1). In our point of view, it has been reported 
that Aloe vera mouthwash may reduce radiation-induced 
OM in HNC patients (9). Also, our previous studies de-
monstrated that some medicinal plants such as bilberry 
(10), St. John’s wort (2) and Marigold (3) could effecti-
vely intervene against development of OM.
Zizyphus jujuba is a thorny rhamnaceous plant that is 
widely distributed in Europe and Southeastern Asia (11). 
Pharmacologically active peptides including cyclopep-
tide alkaloids, flavonoids, sterols, jujuboside A, jujubo-
side B, lauric acid, and triterpenoid saponins have been 
isolated and chemically identified from different species 
of Z. jujuba (12). Fruits of this plant are edible and di-
fferent parts of Z. jujuba possess multiple medicinal pro-
perties such as antifertility, analgesic, and antidiabetes 
(11). It also has been used as tranquilizer, analgesic, and 
anticonvulsant in folk medicine in India (13). However, 
there are no scientific studies about the effect of Z. juju-
ba fruit in prevention and treating of OM. Considering 
the debilitating conditions that OM induced by chemo-
radiotherapy can cause in cancer patients and the lack 
of a definite treatment strategy, and based on the data 
implicating the anti-inflammatory, analgesic and wound 
healing activities of Z. jujube, we decided to evaluate 
and compare the effects of  hydroalcoholic extract of the 
fruit of Z. jujuba in two forms, topical and dietary, on 
5-FU induced OM in golden hamster.
Material and Methods 
-Animals and housing
This study was approved by the Research and Ethics 
Committee of Shiraz University of Medical Sciences, 
and all relevant considerations about animal rights were 
taken into this study. This randomized animal trial was 
performed in the Laboratory Animal Center of Shiraz 
University of Medical Sciences. Fifty six male golden 
hamsters (100 to 120 g, 6-8 weeks old) were taken from 
Laboratory Animal Center of Shiraz University of Me-
dical Sciences, Shiraz, Iran and were housed in standard 
cages under a 12-h light cycle (lights on at 7:00 pm) with 
an ambient temperature of 22 ± 2°C, and 55% relative 
humidity. Hamsters were given a 3-day acclimation pe-
riod with an access to normal chow and water ad libitum 
before the experiment. During their stay in the respec-
tive housing conditions, they were removed from their 
cages every 3 days for cleaning the cages and renewing 
their food and water supply. During the experiment, ac-
cess to standard laboratory diet and water was allowed 
ad libitum. 
-Preparation of hydroalcoholic extract
The fruit of Z. jujube was collected from Shiraz in the 
Fars province of Iran. The fruits were dried at room 
temperature and powdered in a grinder. Aqueous etha-
nol (75%) was added to the powdered materials (500 g), 
and stirred for one hour. The mixture was kept at room 
temperature for 48 hours. Following filtration, ethanol 
was evaporated under reduced pressure at 40ºC. The re-
mained water extract was dried at oven temperature of 
50ºC. Finally, 20% Z. jujube hydroalcoholic extract was 
prepared in pharmacy laboratory.
-Chemotherapy induced OM
Fifty six adult male golden hamsters were randomly allo-
cated into four groups (14 hamsters in each group). All 
animals received three intraperitoneal injections of 5-FU 
on days 0, 5, and 10 at a dose of 60 mg/kg with insulin 
needles following the protocol proposed by Sonis et al. 
(14). To mimic the clinical effect of chronic irritation, 
the cheek pouch mucosa was scratched superficially 
with the tip of an 18-gauge sterile needle after anestheti-
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zing the area. Two horizontal linear scratches were made 
across the everted cheek pouch once daily on days 3 and 
4. The treatment was started on day 12 and 1st group 
of hamsters served as controls and didn’t receive any 
treatment; group 2 received gel base used in preparation 
of the topical gel; group 3 were treated with topical Z. 
jujuba extract gel 20% on the cheek pouch mucosa of 
both sides once a day (morning) and the affected area 
was completely covered. Group 4 were fed Z. jujuba 
hydroalcoholic extract with dose 300 mg/kg once a day 
(morning) in dietary root during study. To make sure that 
it was not swallowed, animals weren’t allowed to eat or 
drink for 30 minutes after the drug applications. Animals 
were weighed daily. Seven hamsters from each group 
were randomly selected for killing on days 14, and 17. 
At the time of sacrifice, they were anesthetized with 100 
mg/kg ketamine 10% (Alfasan, Netherlands) and 10 mg/
kg xylasine 2% (Alfasan, Netherlands). 
-Histopathological study
The both side cheek pouch tissue of hamsters in all groups 
were harvested on day 14 and 17. Tissue obtained from 
the right side pouch was proceed and stained with hema-
toxylin-eosin according to previous reported procedure 
(15-17). The specimens were examined histopathologica-
lly and received scores of 0 to 3, as follows (18): 
- Score 0, normal epithelium and connective tissue wi-
thout vasodilatation; absent or mild inflammatory infil-
trate; absence of bleeding, ulcers and abscesses
- Score 1, mild vascular hyperemia; areas of reepithelia-
lization; mild inflammatory infiltrate with a prevalence 
of mononuclear cells; no hemorrhagic areas, ulcerations 
or abscesses
- Score 2, moderate vascular redness; areas of epithelial 
degeneration; inflammatory infiltration with prevalence 
of neutrophils; hemorrhagic areas, edema and occasio-
nal ulcerations; absence of abscesses
- Score 3, severe hyperemia and vascular vasodilatation; 
inflammatory infiltration
-Measurement of malondialdehyde (MDA)
Tissues obtained from the left side pouch were stored 
under liquid nitrogen until measurment. Tissue malon-
dialdehyde (MDA) assessment was performed via the 
measurement of thiobarbituric acid reactive substances 
(TBARS) in PBS tissue homogenate (19), because MDA 
is one of the end-products of lipid peroxidation (LPO), 
and the extent of LPO is most  frequently measured by 
estimating MDA levels (20). 
-Superoxide dismutase (SOD) assay
Total SOD activity was evaluated with SOD detection 
kit (BiorexFars, Iran) according to the manufacturer’s 
instructions. The role of SOD is to accelerate the dis-
mutation of the toxic superoxide (O2−) produced during 
oxidative energy processes to hydrogen peroxide and 
molecular oxygen. This method employs xanthine and 
xanthine oxidase (XOD) to generate superoxide radicals 
which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-
phenyltetrazolium chloride (INT) to form a red forma-
zan dye. The SOD activity is then measured by degree 
of inhibition of this reaction. One unit of SOD is that 
which causes 50% inhibition of the rate of reduction of 
INT under the conditions of the assay. SOD levels were 
recorded at 505 nm and through a standard curve and 
expressed as U/g wet tissue.
-Myeloperoxidase (MPO) assay
MPO activity can be measured in tissues by assays using 
hydrogen peroxide and o-dianisidine dihydrochloride 
as substrates (21). Briefly, cheek pouch tissues which 
collected on days 14 and 17, were weighed and homo-
genized in a solution containing 0.5% (w/v) hexadecyl-
trimethylammonium bromide dissolved in 10 mmol/L 
potassium phosphate buffer (pH 7.4) and centrifuged for 
30 minutes at 20,000 g at 4°C. An aliquot of superna-
tant was then removed and added to a reaction mixtu-
re containing 1.6 mmol/L tetramethylbenzidine and 0.1 
mmol/L hydrogen peroxide (H2O2). The rate of change 
in absorbance was measured spectrophotometrically at 
650 nm. MPO activity was defined as the quantity of 
enzyme required to degrade 1 mmol of H2O2 at 37°C and 
was expressed in U/g wet tissue.
-Statistical analysis
All statistical analyses were carried out using SPSS® 
statistical software, version 20.0 (SPSS Inc., Chicago, 
IL, USA) for Windows®. Data are expressed as the 
mean ± standard deviation (SD) from all independent ex-
periments. One-Sample-Kolmogorov-Smirnov test was 
used to test for normality of distribution of the collected 
data. A two tailed paired sample T tests were used to 
compare MDA level, SOD and MPO activities and pa-
thology score between days 14 and 17 in control group 
and treatment groups. Differences were considered sig-
nificant when P<0.05. 
Results
-Histopathology evaluation
The maximum severity of OM was seen on day 12 (base 
on clinical examination) and the treatment thus was star-
ted on this day. There is no histopathologic score (HPS) 
difference between the gel base and control groups and 
between the topical gel and systemic treatment groups on 
both days. Also, only significant decreases are seen after 
5 days treatment in comparison to 2 days treatment in the 
HPS in response to topical gel and systemic treatment 
groups (P<0.05). These declines indicating less severe 
inflammation in the topical gel and systemic treatment 
groups (Fig. 1). Epithelialization and wound healing 
were detected in the topical gel and systemic treatment 
groups, whereas extensive infiltration of inflammatory 
cells, hemorrhage and ulcer were observed in the control 
and gel base groups. On days 12 and 17, HPS for the 
topical gel and systemic treatment groups were less than 
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Fig. 1. The histopathology lesions a) and score b) comparison between four different groups in two days of sam-
pling. In histopathological slides, left is score 0 and right is score 3. Significant differences (P<0.05) between 
two days were indicated by asterisk.
gel base group (P<0.001). Also on these two days, HPS 
for the topical gel and systemic treatment groups were 
less than that for the control group (P<0.001).
-Tissue MDA level
Tissue MDA concentration in experimental groups on 2 
and 5 days after onset of treatment are shown in figure 2. 
There are significant differences between MDA concentra-
tions in all four groups between days 2 and 5. Also, MDA 
concentration is higher in the control and gel base groups 
than in the topical gel and systemic treatment groups on 
all days (P<0.001). Although, MDA concentration of the 
topical gel was higher than the systemic treatment group 
on day 14 (P=0.026), but on day 17, MDA level in the 
topical gel was lower than the systemic treatment group 
(P=0.728). Totally, both systemic and topical treatment 
could diminish the MDA level obviously.
-Tissue MPO activity 
Tissue MPO activity in experimental groups on 2 and 
5 days after onset of treatment are shown in figure 3. 
There are significant differences between MPO activity 
in all four groups between days 2 and 5. Also, MPO had 
more activity in the systemic treatment and the topical gel 
groups than in the control and gel base groups on all days 
(P<0.001). Difference between the control and gel base 
groups and also between the systemic treatment and the 
topical gel groups on day 14 (2 days after treatment) were 
not significant (P=0.987 and P=0.180, respectively). On 
day 17 (5 days after treatment) significant differences were 
detected between the systemic treatment and the topical 
Fig. 2. The mean ± SD comparison of malondialdehyde (MDA) con-
centration between four different groups in two days of sampling. 
Significant differences (P<0.05) between two days were indicated 
by asterisk.
Fig. 3. The mean ± SD comparison of myeloperoxidase (MPO) acti-
vity between four different groups in two days of sampling. Sig-
nificant differences (P<0.05) between two days were indicated by 
asterisk.
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gel groups (P=0.001), between the systemic treatment 
and the control and gel base groups (P<0.001) and bet-
ween the topical gel and the control and gel base groups 
(P<0.001). On day 17, there was no significant difference 
between the control and gel base groups (P=0.058).
-Tissue SOD activity 
Tissue SOD activity in experimental groups on 2 and 
5 days after onset of treatment are shown in figure 4. 
There are significant differences between SOD acti-
vity only in the systemic treatment and the topical gel 
groups between days 2 and 5. SOD had more activity in 
the systemic treatment and the topical gel groups than 
the control and gel base groups on all days (P<0.001). 
Although, difference between the control and gel base 
groups on day 14 (2 days after treatment) was not signi-
ficant (P=0.996), but on this day, the systemic treatment 
and the topical gel groups showed significant differen-
ce (P<0.001). On day 17 (5 days after treatment) sig-
nificant differences were detected between the systemic 
treatment and the topical gel groups (P=0.001), between 
the systemic treatment and the control and gel base 
groups (P<0.001) and between the topical gel and the 
control and gel base groups (P<0.001). On day 17, the-
re was no significant difference between the control and 
gel base groups (P=0.222).
Fig. 4. The mean ± SD comparison of superoxide dismutase (SOD) 
activity between four different groups in two days of sampling. Sig-
nificant differences (P<0.05) between two days were indicated by 
asterisk.
Discussion
This study compared the effects of two different drug 
forms of Z. jujuba extract, topical gel 20% and 300 mg/
kg dietary forms, on the healing of OM induced by 5-FU 
in golden hamster. Our results demonstrated that all two 
drug forms can induce wound healing by decreasing 
MDA concentration and elevating MPO and SOD acti-
vity. Also, the systemic dietary form was approximately 
more potent than topical gel.     
Although, inflammatory diseases are currently treated 
with steroidal and non-steroidal anti-inflammatory drugs 
(NSAIDs) (1), but, there are several reports about the 
healing and anti-inflammatory effects of recombinant 
proteins and medicinal plants in OM, as an inflamma-
tory disease of oral mucosa, in human and animal mo-
dels (2-4,10,18,22-25). OM is the most prevalent side 
effect of the anticancer treatment, accounting for more 
than 90% of patients receiving radiotherapy to treat 
HNC (26). In two randomized, placebo-controlled trials 
conducted in HNC patients undergoing postoperative 
chemoradiotherapy and in patients receiving definitive 
chemoradiotherapy for locally advanced HNC, intrave-
nous palifermin, a truncated human recombinant kerati-
nocyte growth factor (KGF), administered weekly for 8 
weeks decreased severe OM (4, 23). On the point of me-
dicinal plant view, the effect of essential oil from seeds 
of Z. jujube on 12-O-tetradecanoylphorbol-13-acetate 
(TPA) induced skin inflammation in experimental mice 
was investigated by Al-Reza and his colleagues. They 
reported that Z. jujuba essential oil inhibited the inflam-
matory responses of skin inflammation in animal model. 
Also, they concluyded that the essential oil of Z. jujuba 
seeds might accelerate the development of new drugs 
for various inflammatory diseases (1). Also, the use of 
mouthwash containing 1% Chamomilla recutita extract 
could be associated with reduced incidence, intensity, 
and duration of mucositis in adults patients undergoing 
allogenic hematopoietic stem cell transplantation which 
suffered from OM (22). In another study, the effecti-
veness of Matricaria recutita Linn (chamomile) in the 
prevention and control of radiation-induced OM was 
evaluated. Their results showed that group with chamo-
mile gel had the faster clinical improvement (24). In all 
previous reports, plants and their extracts had no pro-
phylactic effect on the onset of OM, but it was proven to 
be effective in decreasing the severity of this condition. 
Also, it has been reported that the beneficial effects of 
these traditional plants may be due to polyphenols con-
tent which reviewed by Varoni et al. (25).
On the other hand, oxidative injury from free radical gene-
ration is involved in the pathophysiology of many human 
diseases (13). Several investigations have been performed 
to elucidate the exact role of highly-specific molecules or 
mechanisms underlying the OM development (7,18,27). 
It has been demonstrated that hydroalcoholic extract of Z. 
jujube can reverse oxidative stress induced by pentylene-
tetrazole (PTZ) and electroshock (13). Our results rende-
red more evidence to the critical role of free radicals and 
protective roles of antioxidative enzymes included SOD 
and MPO in pathogenesis of OM. These protective effects 
are useful seen in the groups receiving systemic and topi-
cal forms of Z. jujube. 
Conclusions
According to the findings of present study, Z. jujube 
might be effective agent in treatment of OM. However, 
further studies must be performed on the finding of its 
active anti-inflammatory and antioxidative components 
in different diseases and clinical trials.
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